Jodi Luchs

1.8k total citations
28 papers, 1.1k citations indexed

About

Jodi Luchs is a scholar working on Public Health, Environmental and Occupational Health, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jodi Luchs has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 17 papers in Ophthalmology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jodi Luchs's work include Ocular Surface and Contact Lens (21 papers), Ocular Infections and Treatments (10 papers) and Corneal Surgery and Treatments (8 papers). Jodi Luchs is often cited by papers focused on Ocular Surface and Contact Lens (21 papers), Ocular Infections and Treatments (10 papers) and Corneal Surgery and Treatments (8 papers). Jodi Luchs collaborates with scholars based in United States, United Kingdom and India. Jodi Luchs's co-authors include Ira J. Udell, Paul Karpecki, Joseph Tauber, Aparna Raychaudhuri, Kenneth Sall, Kenneth A. Beckman, Mark S. Milner, Jason Bacharach, Robert Latkany and Charles P. Semba and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Jodi Luchs

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jodi Luchs United States 16 745 451 293 262 178 28 1.1k
Peter C. Donshik United States 21 879 1.2× 351 0.8× 484 1.7× 182 0.7× 172 1.0× 44 1.1k
Dilek Dursun Türkiye 17 1.4k 1.9× 867 1.9× 875 3.0× 180 0.7× 249 1.4× 32 1.8k
Jerry R. Paugh United States 18 1.5k 2.0× 805 1.8× 695 2.4× 301 1.1× 362 2.0× 48 1.6k
Mario A. Di Pascuale United States 15 759 1.0× 322 0.7× 626 2.1× 116 0.4× 350 2.0× 20 1.2k
Andrew D. Pucker United States 19 918 1.2× 433 1.0× 517 1.8× 147 0.6× 152 0.9× 62 1.1k
Ömür Ö. Uçakhan Türkiye 18 1.1k 1.5× 954 2.1× 1.2k 3.9× 146 0.6× 137 0.8× 59 1.7k
Naoko Asano‐Kato Japan 19 740 1.0× 536 1.2× 747 2.5× 174 0.7× 139 0.8× 40 1.2k
E. Goto Japan 7 593 0.8× 251 0.6× 361 1.2× 72 0.3× 88 0.5× 15 712
Sharon D’Souza India 19 591 0.8× 351 0.8× 560 1.9× 71 0.3× 81 0.5× 62 972
Srihari Narayanan United States 12 501 0.7× 205 0.5× 274 0.9× 106 0.4× 88 0.5× 18 625

Countries citing papers authored by Jodi Luchs

Since Specialization
Citations

This map shows the geographic impact of Jodi Luchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi Luchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi Luchs more than expected).

Fields of papers citing papers by Jodi Luchs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi Luchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi Luchs. The network helps show where Jodi Luchs may publish in the future.

Co-authorship network of co-authors of Jodi Luchs

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi Luchs. A scholar is included among the top collaborators of Jodi Luchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi Luchs. Jodi Luchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schechter, Barry A., et al.. (2022). Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial. Clinical ophthalmology. Volume 16. 4145–4151. 6 indexed citations
2.
Sheppard, John D., et al.. (2021). Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca. Clinical ophthalmology. Volume 15. 129–140. 9 indexed citations
3.
Beckman, Kenneth A., Mark S. Milner, Parag A. Majmudar, & Jodi Luchs. (2020). Late-onset fungal interface keratitis following endothelial keratoplasty with positive donor fungal culture. American Journal of Ophthalmology Case Reports. 18. 100707–100707. 13 indexed citations
4.
Lee, Bridgitte Shen, et al.. (2020). <p>Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies</p>. Clinical ophthalmology. Volume 14. 119–126. 40 indexed citations
5.
Sheppard, John D., Jodi Luchs, Ranjan Malhotra, et al.. (2019). Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study. Eye & Contact Lens Science & Clinical Practice. 46(1). S14–S19. 20 indexed citations
6.
Smyth-Medina, Robert, Barry A. Schechter, Bridgitte Shen Lee, et al.. (2019). Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials. Journal of Ocular Pharmacology and Therapeutics. 35(7). 388–394. 12 indexed citations
7.
Yeu, Elizabeth, Damien F. Goldberg, Francis S. Mah, et al.. (2019). <p>Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease</p>. Clinical ophthalmology. Volume 13. 887–894. 15 indexed citations
8.
Tauber, Joseph, Barry A. Schechter, Jason Bacharach, et al.. (2018). A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease. Clinical ophthalmology. Volume 12. 1921–1929. 51 indexed citations
9.
Beckman, Kenneth A., Jodi Luchs, Mark S. Milner, & Julian L. Ambrus. (2017). The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren’s Syndrome Diagnosis. Advances in Therapy. 34(4). 799–812. 24 indexed citations
10.
Holland, Edward J., Jodi Luchs, Paul Karpecki, et al.. (2016). Lifitegrast for the Treatment of Dry Eye Disease. Ophthalmology. 124(1). 53–60. 151 indexed citations
11.
Tauber, Joseph, Paul Karpecki, Robert Latkany, et al.. (2015). Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease. Ophthalmology. 122(12). 2423–2431. 149 indexed citations
12.
Beckman, Kenneth A., Jodi Luchs, & Mark S. Milner. (2015). Making the diagnosis of Sj&ouml;gren&rsquo;s syndrome in patients with dry eye. Clinical ophthalmology. 10. 43–43. 38 indexed citations
13.
Sambursky, Robert, William Trattler, Shachar Tauber, et al.. (2013). Sensitivity and Specificity of the AdenoPlus Test for Diagnosing Adenoviral Conjunctivitis. JAMA Ophthalmology. 131(1). 17–17. 31 indexed citations
14.
Luchs, Jodi. (2010). Efficacy of Hydroxypropyl Cellulose Ophthalmic Inserts (HCOI) in Dry Eye Syndrome (DES) at All Levels of Severity. Investigative Ophthalmology & Visual Science. 51(13). 6262–6262. 1 indexed citations
15.
Luchs, Jodi. (2010). Azithromycin in DuraSite&reg; for the treatment of blepharitis. Clinical ophthalmology. 4. 681–681. 33 indexed citations
16.
Deramo, Vincent, et al.. (2007). Visual Outcome and Bacterial Sensitivity After MRSA-Associated Acute Endophthalmitis. Investigative Ophthalmology & Visual Science. 48(13). 693–693. 1 indexed citations
17.
Trattler, William, Jodi Luchs, & Parag A. Majmudar. (2006). Elestat (Epinastine HCl Ophthalmic Solution 0.05%) as a Therapeutic for Allergic Conjunctivitis. International Ophthalmology Clinics. 46(4). 87–99. 10 indexed citations
18.
Luchs, Jodi, et al.. (2001). Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 108(5). 936–944. 195 indexed citations
19.
Fonacier, Luz, Jodi Luchs, & Ira J. Udell. (2001). Ocular allergies. Current Allergy and Asthma Reports. 1(4). 389–396. 7 indexed citations
20.
Varssano, David, Christopher J. Rapuano, & Jodi Luchs. (1997). Comparison of keratometric values of healthy and diseased eyes measured by javal keratometer, EyeSys, and PAR. Journal of Cataract & Refractive Surgery. 23(3). 419–422. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026